Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018)
Sutro Biopharma (STRO) posted Other Non Operating Income of $1.1 million for Q4 2018, up 1677.94% sequentially from -$68000.0 in Q3 2018, and up 794.17% YoY from $120000.0 in Q4 2017.
Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018) Analysis & Trends
Sutro Biopharma has reported Other Non Operating Income for 2 years, with the latest figure at $1.1 million in Q4 2018.
- Quarterly Other Non Operating Income rose 794.17% year-over-year to $1.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $945000.0 (changed N/A YoY) and the FY2025 annual result came in at $148000.0, changed N/A from the prior year.
- Other Non Operating Income rose to $1.1 million in Q4 2018 per STRO's latest filing, from -$68000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.1 million in Q4 2018 and troughed at -$180000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.07 Mn |
| Sep 30, 2018 | -68,000.00 |
| Dec 31, 2017 | 120,000.00 |
| Sep 30, 2017 | -180,000.00 |